KBRA Releases Research – 2025 European Securitisation: Expanding Volumes, Expanding Reach

NEW YORK--(BUSINESS WIRE)-- KBRA releases research examining European securitisation market activity and the funding strategies observed in 2025.

European securitisation issuance totalled approximately EUR308.9 billion in full-year 2025, reflecting a strong period of market activity and a continued normalisation of funding strategies. New issuance sold to investors (newly circulated) reached EUR168.1 billion, accounting for more than one-half of total volumes and marking one of the strongest years for capital markets distribution since the global financial crisis.

Click here to view the report.

Recent Publications

• 2026 European Structured Finance Sector Outlook: Resilient Foundations Supporting Continued Growth
• Heating up European ABS: Heat Pump Finance and Securitisation
• Breaking the Ratchet: Assessing the Proposed Ban on Upwards-Only Rent Reviews
• European CLO Manager Style Comparisons: September 2025 Update
• Dutch Housing Market Update: Resilience Amid Regulatory Realignment

About KBRA

KBRA, one of the major credit rating agencies, is registered in the U.S., EU, and the UK. KBRA is recognized as a Qualified Rating Agency in Taiwan, and is also a Designated Rating Organization for structured finance ratings in Canada. As a full-service credit rating agency, investors can use KBRA ratings for regulatory capital purposes in multiple jurisdictions.

Doc ID: 1013188

View source version on businesswire.com: https://www.businesswire.com/news/home/20260126640638/en/

Brian Ford, Managing Director
+1 646-731-2329
[email protected]

Killian Walsh, Managing Director
+353 1 588 1184
[email protected]

Kali Sirugudi, Managing Director
+44 20 8148 1050
[email protected]

Media Contact

Matt Turner, Associate Director
+353 1 588 1231
[email protected]

Business Development Contact

Miten Amin, Managing Director
+44 20 8148 1002
[email protected]

Source: Kroll Bond Rating Agency, LLC

You May Also Be Interested In

• Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
• FLUENT Reports Second Quarter 2026 Results
• Video - CEO Clips: Metalero Mining Advances District-Scale Exploration Next to a World-Class Silver Mine